Health
Molina Healthcare Investors Urged to Join Class Action by Rosen Law
The Rosen Law Firm, a prominent global investor rights law firm, is advising investors who purchased securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025, and July 23, 2025, to consider joining a class action lawsuit. The deadline for lead plaintiff applications is set for December 2, 2025.
Investors who acquired Molina securities during this specific period may be entitled to compensation without incurring out-of-pocket expenses, thanks to a contingency fee arrangement. The firm has already initiated a class action suit, allowing affected investors to participate in seeking recovery.
Details of the Class Action
The lawsuit alleges that during the class period, Molina Healthcare failed to disclose significant adverse information regarding its financial health and operational performance. Specifically, the company did not inform investors about:
The material, adverse facts concerning Molina’s “medical cost trend assumptions” and the dislocation between premium rates and medical costs.
Additionally, it is claimed that Molina’s short-term growth relied heavily on a lack of utilization of behavioral health, pharmacy, and inpatient and outpatient services. Consequently, this failure to disclose has led to misleading statements about the company’s business and prospects.
When these realities came to light, investors reportedly suffered financial damages. As a result, those who purchased Molina securities during the specified class period are encouraged to act promptly.
How to Participate
Individuals interested in joining the Molina class action can visit this link, or contact Phillip Kim, Esq. toll-free at 866-767-3653 or via email at [email protected]. It is important to note that until the class is certified, investors are not represented by counsel unless they retain one themselves.
Investors can choose to remain absent class members or select their own counsel. Participation as a lead plaintiff, which involves representing the interests of the class, must occur by the deadline of December 2, 2025.
Why Choose Rosen Law Firm?
The Rosen Law Firm emphasizes the importance of selecting qualified legal representation with a proven track record in securities class actions. The firm has achieved notable success, including the largest securities class action settlement against a Chinese company at the time. In 2017, it was ranked first by ISS Securities Class Action Services for the number of settlements, and it has consistently ranked among the top firms since.
In 2019 alone, the firm secured over $438 million for investors. Founding partner Laurence Rosen received recognition from Law360 as a Titan of the Plaintiffs’ Bar in 2020, highlighting the firm’s capability in navigating complex securities litigation.
Investors are encouraged to stay informed by following the Rosen Law Firm on social media platforms such as LinkedIn, Twitter, and Facebook.
For further updates and information regarding the class action, interested parties can reach out using the contact details provided. As a reminder, previous results do not guarantee similar outcomes in future cases.
-
Science3 weeks agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health4 weeks agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories4 weeks agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment4 weeks agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Business4 weeks agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Entertainment4 weeks agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
World4 weeks agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Health4 weeks agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Entertainment4 weeks agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
-
Top Stories3 weeks agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
-
Science4 weeks agoNorth Carolina’s Biotech Boom: Billions Invested in Manufacturing
-
Health4 weeks agoNorth Carolina’s Biotech Boom: Billions in New Investments
